Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

746
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

511
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An impaired intrinsic microglial clock system induces neuroinflammatory alterations in the early stage of amyloid precursor protein knock-in mouse brain.

Journal of neuroinflammation·2019
Same author

Childhood-onset cerebellar ataxia in Japan: A questionnaire-based survey.

Brain and behavior·2019
Same author

Inhibition of p38 MAPK in the brain through nasal administration of p38 inhibitor loaded in chitosan nanocapsules.

Nanomedicine (London, England)·2019
Same author

Solvent-Coordinated Tin Halide Complexes as Purified Precursors for Tin-Based Perovskites.

ACS omega·2019
Same author

Patient Transfer to Receive Proton Beam Therapy During Intensive Multimodal Therapy is Safe and Feasible for Patients With Newly Diagnosed High-risk Neuroblastoma.

Journal of pediatric hematology/oncology·2019
Same author

Insoluble Aβ overexpression in an <i>App</i> knock-in mouse model alters microstructure and gamma oscillations in the prefrontal cortex, affecting anxiety-related behaviours.

Disease models & mechanisms·2019

Related Experiment Video

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

Biomarkers.

Tatsuya Manabe1, Takuto Iida1, Takashi Saito1

  • 1Nagoya City University, Nagoya, Aichi, Japan.

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|December 25, 2025
PubMed
Summary

Chronic kidney disease (CKD) in aged mice elevates brain tau phosphorylation, suggesting a kidney-brain axis. This research explores how CKD impacts tau pathology and neuroinflammation in aging populations.

Area of Science:

  • Neuroscience
  • Nephrology
  • Biochemistry

Background:

  • Alzheimer's disease (AD) is characterized by beta-amyloid (Aβ) plaques.
  • Phosphorylated tau protein (p-tau) is a biomarker for Aβ burden, with blood levels of p-tau181 and p-tau217 indicating preclinical AD.
  • Chronic kidney disease (CKD) can elevate p-tau independently of Aβ pathology.

Purpose of the Study:

  • Investigate the link between CKD and elevated circulating p-tau.
  • Determine if CKD-induced brain p-tau elevation contributes to increased blood p-tau.
  • Utilize a mouse model to understand the kidney-brain axis in CKD.

Main Methods:

  • Induced CKD in mice using an adenine-rich diet.
  • Assessed renal function via histology and biochemical markers.

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

Related Experiment Videos

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699
  • Evaluated brain tau phosphorylation (p-tau181, p-tau217, p-tau396) using western blot.
  • Quantified microglial morphology to assess neuroinflammation.
  • Main Results:

    • Adenine induced renal fibrosis and elevated plasma uremic toxins, with age-dependent severity.
    • Aged CKD mice exhibited heightened levels of p-tau181, p-tau217, and p-tau396 in the brain.
    • CKD led to reduced microglial ramification in aged mice, indicating neuroinflammation.

    Conclusions:

    • Adenine successfully modeled CKD pathology within six weeks.
    • Aged mice showed more severe renal dysfunction and delayed recovery.
    • Altered brain p-tau and neuroinflammation in aged CKD mice highlight a novel kidney-brain axis relevant to elderly patients.